期刊文献+

趋化因子受体CCR7在T细胞淋巴瘤播散中的作用

The Role of Chemokine Receptor CCR7 in Dissemination of T Cell Lymphoma
下载PDF
导出
摘要 目的:探讨趋化因子受体CCR7在T细胞淋巴瘤播散中的作用;旨在为T细胞淋巴瘤靶点治疗的新方向提供一定的实验基础及理论依据。方法:皮肤T细胞淋巴瘤Hut78和成人T淋巴细胞白血病/淋巴瘤Jurkat细胞株培养,通过Transwell小室检测了细胞体外侵袭能力并进行比较;通过RT-PCR和Western-blot技术对两种细胞株的CCR7和PI_3K/A kt信号转导通路的表达进行了检测。结果:1)Hut78细胞体外侵袭能力较强;两种T细胞淋巴瘤细胞经过CCL21共培养后,侵袭能力均有所增强,且均呈现与CCL21浓度的正相关趋势;2)Hut78细胞中CCR7mRNA,PI_3KmRNA、AktmRNA均高于Jurkat细胞,差异均有显著性(P<0.001);CCR7、pAkt蛋白在Hut78细胞中的表达也明显高于Jurkat细胞(P<0.05)。结论:T细胞淋巴瘤中高表达的CCR7与肿瘤的侵袭性有关,可能通过PI_3K/Akt信号通路促进肿瘤的侵袭和播散。 Objective: To explore the role and mechanisms of chemokine receptors in the T-cell lymphoma invasion process in order to provide experimental and theoretical basis for target therapy of T-cell lymphoma. Methods: The cutaneous T-cell lymphoma Hut78 and adult T-cell leukemia/lymphoma Jurkat cell lines were co-cultured. The in vitro invasive ability of the two cell lines was measured by Transwell invasion assay. The transcription and expression of CCR7 and key enzymes in PI3K/Akt pathway were evaluated using RT-PCR and Western blot. Results: Hut78 cell lines showed a stronger invasive ability in the Transwell assay. After the two cell lines were co-cultured with chemokine CCL21, their invasive ability was increased. The invasive ability displayed a positive correlation with the CCL21 concentration. The CCR7 mRNA, PI3K mRNA and Akt mRNA expression was all higher in Hut78 cell line than in Jurkat cell line, with significant differences ( P 〈 0.001 ). The expression of CCR7 and pAkt protein was significantly higher in Hut78 cell line than in Jurkat cell line ( P 〈 0.05 ). Conclusion: The high expression of CCR7 in T-cell lymphoma is related to the invasion of tumors. CCR7 may promote tumor invasion and metastasis through the PI3K/Akt signal pathways.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2011年第7期367-371,共5页 Chinese Journal of Clinical Oncology
基金 天津市科技支撑项目基金资助(编号:09ZCZDSF04400)~~
关键词 CCR7 PI3K/AKT信号转导通路 T细胞淋巴瘤 CCR7 PI3K/Akt signal transduction pathway T cell lymphoma
  • 相关文献

参考文献15

  • 1Yoshida R,Nagira M,Kitaura M,et al.Secondary lymphoid-tissue chemokine is a funcdonal ligand for the CC chemokine receptor CCR7[J].J Biol Chem,1998,273(12):7118-7122.
  • 2Dieu MC,Vanbervliet B,Vicari A,et al.Selective recruitment of immature and mature dendritic cells by distinct chemokines expressed in different anatomic sites[J].J Exp Med,1998,188(2):373-386.
  • 3Hirao M,Onai N,Hiroishi K,et al.CC chemokine receptor-7 on dendritic cells is induced after interaction with apoptotic tumor cells:critical role in migration from the tumor site to draining lymph nodes[J].Gancer Res,2000,60(8):2209-2217.
  • 4Forster R,Davalos-Misslitz AC,Rot A.CCR7 and its ligands:balancing immunity and tolerance[J].Nat Rev Immunol,2008,8(5):362-371.
  • 5Cabioglu N,Yazici MS,Arun B,et al.CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1breast cancer[J].Clin Cancer Res,2005,11 (16):5686-5693.
  • 6Li S,Huang S,Peng SB.Overexpression of G protein-coupled receptors in cancer cells:involvement in tumor progression[J].Int J Oncol,2005,27(5):1329-1339.
  • 7Takanami I.Overexpression of CCR7 mRNA in nonsmall cell lung cancer:correlation with lymph node metastasis[J].IntJ Cancer,2003,105(2):186-189.
  • 8Mǖller A,Homey B,Soto H,et al.Involvement of chemokine receptors in breast cancer metastasis[J].Nature,2001,410(6824):50-56.
  • 9Hasegawa H,Nomura T,Kohno M,et al.Increased chemokine receptor CCR7/EBI1 expression enhances the infiltration of lymphoid organs by adult T-cell leukemia cells[J].Blood,2000,95(1):30-38.
  • 10朱栋元,马廷行,唐晓勇.非小细胞肺癌组织中趋化因子受体CCR7、CXCR4表达及其临床意义[J].山东医药,2006,46(11):1-3. 被引量:9

二级参考文献37

  • 1[1]Yoshie O, Imai T, Nomiyama H. Chemokines in immunity[J]. Adv Immunol, 2001,78:57-110.
  • 2[2]Cascieri MA, Springer MS. The chemokine/chemokine-receptor family: potential and progress for therapeutic interven-tion[J]. Curr Opin Chem Bio,2000,4(4):420-427.
  • 3[3]Christopherson K 2nd, Hromas R. Chemokine regulation of normal and pathologic immune responses[J]. Stem Cells,2001,19(5):388-396.
  • 4[4]Murphy PM, Baggiolini M, Charo IF. International union of pharmacology. XXII. Nomenclature for chemokine receptors[J]. Pharmacol Rev,2000,52(1): 145-176.
  • 5[5]Fernandez EJ, Lolis E. Structure, function, and inhibition of chemokines[J]. Annu Rev Pharmacol Toxicol,2002,42:469-499.
  • 6[6]Luo J, Luo Z, Zhou N, et al. Attachment of C-terminus of SDF-1 enhances the biological activity of its N-terminal peptide[J]. Bioch Biophy Res Communicat,1999,264(1):42-47.
  • 7[7]Amara A, Lorthioir O, Valenzuela A, et al. SDF-1( associates with heparin sulfates through the first β-strand of the chemokine[J]. J Bio Chem,1999,274(34):23 916-23 925.
  • 8[8]Campbell JJ,Butcher EC. Chemokines in tissue-specific and microenvironment-specific lymphocyte homing[J]. Cur Opin Immunol,2000,12(3):336-341.
  • 9[9]Campbell JJ, Hedrick J, Zlotnik A, et al. Chemokines and the arrest of lymphocytes rolling under flow conditions[J]. Scuence,1998,279(5 349):381-384.
  • 10[10]Hoogewerf AJ, Kuschert GS, Proudfoot AE,et al. Glycosaminoglycans mediate cell surface oligomerization of chemokines[J]. Biochemistry,1997,36(44):13 570-13 578.

共引文献59

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部